Request Demo
Last update 29 Jul 2025
UCMYM-802
Last update 29 Jul 2025
Overview
Basic Info
Drug Type Autologous CAR-T |
Synonyms MSLN CART(CRNA) (UTC Therapeutics), UCMYM 802, UCMYM-802 + [1] |
Target |
Action inhibitors |
Mechanism MSLN inhibitors(Mesothelin inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with UCMYM-802NCT06256055
A First-In-Human, Single Arm, Open-label, Phase 1 Dose-Escalation Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors
CTR20233925
UCMYM802注射液治疗MSLN阳性晚期实体肿瘤患者的首次人体、开放、单臂、剂量递增的I期临床试验
[Translation] A first-in-human, open-label, single-arm, dose-escalating Phase I clinical trial of UCMYM802 injection in patients with MSLN-positive advanced solid tumors
100 Clinical Results associated with UCMYM-802
Login to view more data
100 Translational Medicine associated with UCMYM-802
Login to view more data
100 Patents (Medical) associated with UCMYM-802
Login to view more data
100 Deals associated with UCMYM-802
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Bile Duct Neoplasms | Phase 1 | China | 05 Mar 2024 | |
| Breast Cancer | Phase 1 | China | 05 Mar 2024 | |
| Mesothelioma, Malignant | Phase 1 | China | 05 Mar 2024 | |
| Ovarian Cancer | Phase 1 | China | 05 Mar 2024 | |
| Pancreatic Cancer | Phase 1 | China | 05 Mar 2024 | |
| Rectal Cancer | Phase 1 | China | 05 Mar 2024 | |
| Mesothelin positive Solid Tumors | Phase 1 | China | 20 Feb 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free